NCT05430113View on ClinicalTrials.gov

Spinal Cord Stimulation in Spinal Muscular Atrophy

NAActive, not recruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 5, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

August 31, 2027

Conditions
Spinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 4
Interventions
DEVICE

Spinal Cord Stimulator (octopolar Medtronic Vectris Leads)

2-4 leads FDA-approved for treatment of symptoms of refractory pain

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

Roche-Genentech

INDUSTRY

lead

Marco Capogrosso

OTHER